Impact of COVID-19 on paediatric chronic intestinal failure: A tertiary care children's hospital experience.

SARS-CoV-2 healthcare utilization quality of life short bowel syndrome

Journal

Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545

Informations de publication

Date de publication:
13 Mar 2024
Historique:
revised: 11 12 2023
received: 10 10 2023
accepted: 22 01 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: aheadofprint

Résumé

Paediatric patients with intestinal failure (IF) are at risk for both gastrointestinal (GI) and systemic complications, thus depending on a functioning network of multidisciplinary care. Data on the clinical impact of coronavirus disease 2019 (COVID-19) or the pandemic-related restrictions are limited. We aimed to analyse the clinical course of COVID-19 in children with IF, and to evaluate the perceived impact of the COVID-19 pandemic on IF patients and their caregivers by analysing quality of life (QoL), health-related QoL (HRQoL) and health care. Children with IF presenting at our intestinal rehabilitation centre were enrolled and interviewed about test-proven COVID-19 infection. A standardised questionnaire was offered to all caregivers of IF patients and to two control groups (children with inflammatory bowel disease and gastrointestinal healthy children). Between December 2020 and November 2022, 25 out of 127 patients with IF contracted COVID-19. Forty-eight per cent had GI symptoms, 32% required additional intravenous fluids and 20% were hospitalized. Only 25% of vaccinated children showed signs of GI dysfunction, compared to 52% of unvaccinated children. Analysis of 93 questionnaires showed a negative impact on QoL and HRQoL (>66.7% and >27.8%, respectively). IF patients frequently experienced restrictions in health care, including appointments, services and supply of parenteral nutrition or medications. Caregiver burden increased significantly more often in caregivers of children with IF (p = 0.007). Paediatric patients with IF contracting COVID-19 have an increased risk for GI dysfunction which may be alleviated by vaccination. Children and their caregivers were highly burdened by pandemic-related restrictions and reductions in health care provision.

Identifiants

pubmed: 38477361
doi: 10.1002/jpn3.12158
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : None

Informations de copyright

© 2024 The Authors. Journal of Pediatric Gastroenterology and Nutrition published by Wiley Periodicals LLC on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Références

Merritt RJ, Cohran V, Raphael BP, et al. Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome. J Pediatr Gastroenterol Nutr. 2017;65:588-596.
Goulet O. Intestinal failure in children. Transpl Proc. 1998;30:2523-2525.
Javid PJ, Wendel D, Horslen SP. Organization and outcomes of multidisciplinary intestinal failure teams. Semin Pediatr Surg. 2018;27:218-222.
McCaig JK, Henry OS, Stamm DA, et al. Generic and disease-specific health-related quality of life in pediatric intestinal failure. J Pediatr Gastroenterol Nutr. 2021;73:338-344.
Belza C, Avitzur Y, Ungar WJ, Stremler R, Fehlings D, Wales PW. Stress, anxiety, depression, and health-related quality of life in caregivers of children with intestinal failure receiving parenteral nutrition: a cross-sectional survey study. J Parent Enteral Nutr. 2023;47:342-353.
Wong CA, Ming D, Maslow G, Gifford EJ. Mitigating the impacts of the COVID-19 pandemic response on at-risk children. Pediatrics. 2020;146:146.
Allan PJ, Pironi L, Joly F, Lal S, Van Gossum A. An international survey of clinicians’ experience caring for patients receiving home parenteral nutrition for chronic intestinal failure during the COVID-19 pandemic. J Parenter Enteral Nutr. 2021;45:43-49.
Galloway DP, Mathis MS, Wilkinson LT, et al. Effect of the COVID-19 pandemic on pediatric intestinal failure healthcare delivery. J Parent Enteral Nutr. 2021;45:50-56.
Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50-54.
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665.
Ashktorab Y, Brim A, Pizuorno A, Gayam V, Nikdel S, Brim H. COVID-19 pediatric patients: gastrointestinal symptoms, presentations, and disparities by race/ethnicity in a large, multicenter US study. Gastroenterology. 2021;160:1842-1844.
Stopyra L, Kowalik A, Stala J, et al. Characteristics of hospitalized pediatric patients in the first five waves of the COVID-19 pandemic in a single center in Poland-1407 cases. J Clin Med. 2022;11(22). doi:10.3390/jcm11226806
Pironi L, Jezerski D, Sobocki J, et al. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure. Clin Nutr ESPEN. 2023;55:212-220.
Ravens-Sieberer U, Kaman A, Erhart M, Devine J, Schlack R, Otto C. Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany. Eur Child Adolesc Psychiatry. 2022;31:879-889.
Adıbelli D, Sümen A. The effect of the coronavirus (COVID-19) pandemic on health-related quality of life in children. Child Youth Serv Rev. 2020;119:105595.
Ravens-Sieberer U, Kaman A, Erhart M, et al. Quality of life and mental health in children and adolescents during the first year of the COVID-19 pandemic: results of a two-wave nationwide population-based study. Eur Child Adolesc Psychiatry. 2023;32:575-588.
Aman NF, Fitzpatrick J, Verteuil Ide, et al. Family functioning and quality of life among children with nephrotic syndrome during the first pandemic wave. Pediatr Nephrol. 2022;38(9):1-6.
Rihm L, Dreier M, Rezvani F, Wiegand-Grefe S, Dirmaier J. The psychosocial situation of families caring for children with rare diseases during the COVID-19 pandemic: results of a cross-sectional online survey. Orphanet J Rare Dis. 2022;17:449.
Önal G, Güney G, Huri M. Quality of life and occupational performance of children with cancer in the era of the COVID-19 pandemic in terms of rehabilitation. Qual Life Res. 2021;30:2783-2794.
Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020;159:481-491.
Fragoso RP, Rodrigues M. COVID-19 and pediatric inflammatory bowel disease: how to manage it? Clinics. 2020;75:e1962.
Remppis J, Hilberath J, Ganzenmüller T, et al. Infection control of COVID-19 in pediatric tertiary care hospitals: challenges and implications for future pandemics. BMC Pediatr. 2022;22:229.
Davis AL, Sunderji A, Marneni SR, et al. Caregiver-reported delay in presentation to pediatric emergency departments for fear of contracting COVID-19: a multi-national cross-sectional study. Can J Emerg Med. 2021;23:778-786.
Neill S, Carter R, Jones R, et al. Caring for a sick or injured child during the COVID-19 pandemic lockdown in 2020 in the UK: an online survey of parents’ experiences. Health Exp Int J Public Participat Health Care Health Policy 2021;24:2036-2046.
Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4:10.
Mercuri E, Zampino G, Morsella A, et al. Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era. Ital J Pediatr. 2021;47:29.
Varni JW, Limbers CA. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatr Clin North Am. 2009;56:843-863.

Auteurs

Johannes Hilberath (J)

Paediatric Gastroenterology and Hepatology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Anna-Sophia Mast (AS)

Department of Haematology and Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Simon Scherer (S)

Paediatric Surgery and Urology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Jörg Fuchs (J)

Paediatric Surgery and Urology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Johannes Schulte (J)

Department of Haematology and Oncology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Ekkehard Sturm (E)

Paediatric Gastroenterology and Hepatology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Steven Warmann (S)

Paediatric Surgery and Urology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Christoph Slavetinsky (C)

Paediatric Surgery and Urology, University Children's Hospital Tübingen, University of Tübingen, Tübingen, Germany.

Classifications MeSH